Literature DB >> 722730

Synthesis and antiviral and enzymatic studies of certain 3-deazaguanines and their imidazolecarboxamide precursors.

P D Cook, L B Allen, D G Streeter, J H Huffman, R W Sidwell, R K Robins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 722730     DOI： 10.1021/jm00210a008

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  5 in total

1.  Studies on the mechanism of 3-deazaguanine cytotoxicity in L1210-sensitive and -resistant cell lines.

Authors:  G Singh; M K Luna; B Ardalan
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  7-Alkyl-N(2)-substituted-3-deazaguanines. Synthesis, DNA polymerase III inhibition and antibacterial activity.

Authors:  Wei-Chu Xu; George E Wright; Neal C Brown; Zheng-Yu Long; Cheng-Xin Zhi; Sofya Dvoskin; Joseph J Gambino; Marjorie H Barnes; Michelle M Butler
Journal:  Bioorg Med Chem Lett       Date:  2011-05-30       Impact factor: 2.823

3.  Studies on the mechanism of cytotoxicity of 3-deazaguanosine in human cancer cells.

Authors:  T Page; S J Jacobsen; R M Smejkal; J Scheele; W L Nyhan; J H Mangum; R K Robins
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

4.  A new synthesis of certain 7-(beta-D-ribofuranosyl) and 7-(2-deoxy-beta-D-ribofuranosyl) derivatives of 3-deazaguanine via the sodium salt glycosylation procedure.

Authors:  P K Gupta; R K Robins; G R Revankar
Journal:  Nucleic Acids Res       Date:  1985-07-25       Impact factor: 16.971

5.  Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin.

Authors:  J J Kirsi; P A McKernan; N J Burns; J A North; B K Murray; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.